New Avon Program Brings 25 Breast Cancer Physicians to U.S. to Learn Advanced Skills and Techniques to help Women in Home Countries
25 Global Scholars to Train at Leading Avon Foundation-funded U.S. Breast Cancer Centers in 2012
NEW YORK, NY (May 10, 2012) – In recognition of the 20th Anniversary of the Avon Breast Cancer Crusade, the Avon Foundation for Women announced its first class of Avon Global Breast Cancer Clinical Scholars at the annual Avon Foundation Breast Cancer Forum on March 21-23 in New York City. The Avon Global Scholars—25 breast cancer specialists from 14 countries—will begin training preceptorships at one of 13 leading Avon Foundation-funded U.S. breast cancer centers in September 2012 with the goal of bringing new skills and information to their home countries that will improve the treatment and care of breast cancer patients.
The Avon Foundation for Women Global Breast Cancer Clinical Scholars Program—first announced by Reese Witherspoon last October during Avon’s 2011 Breast Cancer Global Congress—provides clinically-focused scholarship opportunities for breast cancer specialists from outside the United States to receive advanced training at leading U.S. breast cancer centers. The program is bringing its first 25 clinician scholars to the United States for a four- to eight-week intensive training/preceptorship in breast cancer surgery, pathology, breast imaging (radiology), medical oncology, clinical trial design and community and public health. The Avon Foundation Scientific Advisory Board and host institution mentors selected the first class of 25 Avon Global Scholars through a rigorous two-stage review process from 85 applicants from 22 countries.
“The Avon Global Breast Cancer Clinical Scholars will receive training from some of the best breast cancer doctors in the United States and will return home with advanced skills and new information that will improve both the treatment and care of women facing breast cancer in their countries,” said Marc Hurlbert, PhD, executive director of the Avon Foundation Breast Cancer Crusade. “The scholars will be training at institutions the Avon Foundation has chosen to fund because of their excellence and advancements in breast cancer research, treatment and access to care.”
The first Avon Global Scholars class includes breast cancer specialists from Armenia, Brazil, China, Colombia, Croatia, India, Kenya, Nigeria, Philippines, Serbia, Turkey, Ukraine, Venezuela and Zambia. The Scholars will arrive in the United States on September 10 in San Francisco to attend the American Society of Clinical Oncology (ASCO) Breast Cancer Symposium, attended by more than 1,100 leading cancer researchers, after which they will begin their fellowships.
The Avon Global Scholars will be studying at the following Avon Foundation-funded breast cancer programs:
- Boston Medical Center, Boston, MA (1 Scholar)
- Emory University-Grady Memorial Hospital, Atlanta, GA (2 Scholars)
- Georgetown University-Capital Breast Care Center, Washington DC (2 Scholars)
- Johns Hopkins University, Baltimore, MD (2 Scholars)
- Magee - Women's Hospital, University of Pittsburgh, Pittsburgh, PA (2 Scholars)
- Massachusetts General Hospital, Boston, MA (2 Scholars)
- New York University-Bellevue Hospital, New York, NY (2 Scholars)
- New York-Presbyterian Hospital-Columbia University Medical Center, New York, NY (2 Scholars)
- Northwestern University, Chicago, IL (2 Scholars)
- Sinai Urban Health Institute, Chicago, IL (2 Scholars)
- University of California Los Angeles-Olive View Medical Center, Los Angeles, CA (2 Scholars)
- University of California San Francisco-San Francisco General Hospital, San Francisco, CA (2 Scholars)
- Washington University St. Louis, St. Louis, MO (2 Scholars)
About the Avon Foundation Breast Cancer Forum
This year’s Avon Foundation Breast Cancer Forum, which focused on disparities in breast cancer care and treatment, convened more than 275 Avon Foundation-funded community health educators, patient navigators, nurses and physicians from all 50 U.S. states to discuss early detection programs and breast cancer treatment. At the Forum, the Avon Foundation released findings from the 2012 Racial Disparity in Breast Cancer Mortality Study, conducted by Sinai Urban Health Institute and funded by the Avon Foundation for Women. The study is the first national study to examine the racial disparity in breast cancer mortality at the city level in the United States. This new Breast Cancer Global Clinical Scholars Program underscores Avon’s commitment to support programs that will reduce disparities in breast cancer treatment and access to care across the US and around the world.
About the Avon Breast Cancer Crusade
The Avon Breast Cancer Crusade, which observes its 20th anniversary in 2012, has placed Avon at the forefront of the fight against breast cancer. Today, Avon is the leading corporate supporter of the cause globally. In the 20 years since the Crusade’s launch, Avon breast cancer programs in 58 countries have donated more than $740 million for research and advancing access to care, regardless of a person’s ability to pay. Avon awards funding to beneficiaries ranging from leading cancer centers to community-based grassroots breast health programs to support breast cancer research and access to care. The Crusade has enabled more than 17 million women globally to receive free mammograms and breast cancer screenings, educated more than 100 million women about breast cancer, and funded promising research into the causes of breast cancer and ways to prevent the disease. Avon raises funds for the Crusade through the sale of Avon “Pink Ribbon” products and through fundraising events in more than 50 countries annually, including the U.S. Avon Walk for Breast Cancer series and Avon Walk Around the World for Breast Cancer events.